NagarajaDSharmaMD

PubMed

• 15 citations
  Accuracy of Uncorrected versus Corrected QT Interval for Prediction of Torsade de Pointes Associated with Intravenous Haloperidol
  James E. Tisdale, Richard J. Kovacs, Deming Mi, George P. McCabe, Beth L Cariera, Nagaraja D. Sharma, Howard S. Rosman> ;Pharmacotherapy. 2007 Feb 1
• 41 citations
  Clinical presentation, hospital length of stay, and readmission rate in patients with heart failure with preserved and decreased left ventricular systolic function.
  Qahtan Malki, Nagaraja D. Sharma, Adnan Afzal, Karthik Ananthsubramaniam, Ali Abbas, Gordon Jacobson, Syed Jafri> ;Clinical Cardiology. 2002 Apr 1
• 54 citations
  The Effect of Intravenous Haloperidol on QT Interval Dispersion in Critically Ill Patients: Comparison with QT Interval Prolongation for Assessment of Risk of Torsades...
  James E. Tisdale, Saeed Rasty, I. Desmond Padhi, Nagaraja D. Sharma, Howard S. Rosman> ;Journal of Clinical Pharmacology. 2001 Dec 1
• Cardiogenic shock secondary to myocardial rupture contained by a thrombus with left atrial and pulmonary venous compression.
  Nagaraja D. Sharma, Amjad Farha, Mohsin Alam> ;Echocardiography. 2000 Feb 1
• 115 citations
  Left ventricular thrombus and subsequent thromboembolism in patients with severe systolic dysfunction.
  Nagaraja D. Sharma, Peter A. McCullough, Edward F. Philbin, W. Douglas Weaver> ;Chest. 2000 Feb 1
• 150 citations
  Torsades de Pointes Associated With Intravenous Haloperidol in Critically Ill Patients
  N D Sharma, Howard S. Rosman, I D Padhi, James E. Tisdale> ;The American Journal of Cardiology. 1998 Jan 15
• Join now to see all